For those that believe in the vision of our CEO, a

For those that believe in the vision of our CEO, a good read on GDR's might provide some insight when you factor in John A. Germinario involvement as Chairman especially when it comes to M&A and cross border transactions. It is interesting to note that GDR's are generally priced in the $7.00 - $20.00 range, are designed for international investors and generally listed on European exchanges in London, Luxembourg,also Hong Kong, Singapore, etc. There are HUGE implications on the scale of this undertaking because it opens up the possibilities of M&A with companies already involved in GDR making very rapid growth/expansion into international markets likely.

Buy and hold, don't worry about MM;s or listen to riffraff, keep your eye on who is getting added to the corporate structure, etc., previously RS being sold into the market will likely be recycled which will financially allow the company to outgrow OTC.

Shareholders just need to be patient here. Look for pps movement on licensing and again in June, then bigger moves with M&A news.

https://www.adr.com/Home/LoadPDF?CMSID=9ed050...27c14dd882